Nuclear receptors, bile acids and cholesterol homeostasis series - Bile acids and pregnancy

Molecular and Cellular Endocrinology

Volumn 368, Issue 1-2, 2013, Pages 120-128

  Abu Hayyeh, Shadi ^a   Papacleovoulou, Georgia ^a   Williamson, Catherine ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bile acid; Fetoplacental unit; Intrahepatic cholestasis of pregnancy; Pregnancy

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL; FARNESOID X RECEPTOR; PLACEBO; URSODEOXYCHOLIC ACID;

BILE ACID METABOLISM; CHOLESTEROL METABOLISM; DRUG EFFICACY; DRUG MECHANISM; ENTEROHEPATIC CIRCULATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME REGULATION; FETOPLACENTAL UNIT; HEREDITY; HOMEOSTASIS; HUMAN; IN VITRO STUDY; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; BILE ACIDS AND SALTS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; CHOLESTEROL; DIET; FEMALE; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; URSODEOXYCHOLIC ACID;

EID: 84875241809     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.10.027     Document Type: Review

References (132)

1. Abdul Kadir S.H., Ali N.N., Mioulane M., Brito-Martins M., Abu-Hayyeh S., Foldes G., Moshkov A.V., Williamson C., Harding S.E., Gorelik J. Embryonic stem cell-derived cardiomyocytes as a model to study fetal arrhythmia related to maternal disease. J. Cell Mol. Med. 2009, 13:3730-3741.
2. +taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites. J. Biol. Chem. 2010, 285:16504-16512.
3. Abu-Hayyeh, S., Papacleovoulou, G., Lövgren-Sandblom, A., Tahir, M., Oduwole, O., Jamaludin, N.A., Ravat, S., Nikolova, V., Chambers, J., Selden, C., Rees, M., Marschall, H.U., Parker, M.G., Williamson, C., 2012. Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit FXR Resulting in a Pro-Cholestatic Phenotype. Hepatology ,. http://dx.doi.org/10.1002/hep.26055.
4. Ahanya S.N., Lakshmanan J., Morgan B.L., Ross M.G. Meconium passage in utero: mechanisms, consequences, and management. Obstet. Gynecol. Surv. 2005, 60:45-56.
5. Bacq Y., Gendrot C., Perrotin F., Lefrou L., Chretien S., Vie-Buret V., Brechot M.C., Andres C.R. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J. Med. Genet. 2009, 46:711-715.
6. Bacq Y., Sentilhes L., Reyes H.B., Glantz A., Kondrackiene J., Binder T., Nicastri P.L., Locatelli A., Floreani A., Hernandez I., Di M.V. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012.
7. Ballatori N. Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta. Exp. Biol. Med. (Maywood.) 2005, 230:689-698.
8. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:318-328.
9. Blazquez A.G., Briz O., Romero M.R., Rosales R., Monte M.J., Vaquero J., Macias R.I., Cassio D., Marin J.J. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol. Pharmacol. 2012, 81:273-283.
10. Boaglio A.C., Zucchetti A.E., Sanchez Pozzi E.J., Pellegrino J.M., Ochoa J.E., Mottino A.D., Vore M., Crocenzi F.A., Roma M.G. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17beta-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C. Hepatology 2010, 52:1465-1476.
11. Bodin K., Lindbom U., Diczfalusy U. Novel pathways of bile acid metabolism involving CYP3A4. Biochim. Biophys. Acta 2005, 1687:84-93.
12. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann. Hepatol. 2002, 1:20-28.
13. Brites D., Rodrigues C.M., Oliveira N., Cardoso M., Graca L.M. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J. Hepatol. 1998, 28:91-98.
14. Campos G.A., Guerra F.A., Israel E.J. Effects of cholic acid infusion in fetal lambs. Acta Obstet. Gynecol. Scand. 1986, 65:23-26.
15. Carlton V.E., Harris B.Z., Puffenberger E.G., Batta A.K., Knisely A.S., Robinson D.L., Strauss K.A., Shneider B.L., Lim W.A., Salen G., Morton D.H., Bull L.N. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat. Genet. 2003, 34:91-96.
16. Castano G., Burgueno A., Fernandez G.T., Pirola C.J., Sookoian S. The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy. Aliment. Pharmacol. Ther. 2010, 31:583-592.
17. Castano G., Lucangioli S., Sookoian S., Mesquida M., Lemberg A., Di S.M., Franchi P., Carducci C., Tripodi V. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin. Sci. (Lond.) 2006, 110:459-465.
18. Ceckova M., Libra A., Pavek P., Nachtigal P., Brabec M., Fuchs R., Staud F. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin. Exp. Pharmacol. Physiol. 2006, 33:58-65.
19. Chappell L.C., Gurung V., Seed P.T., Chambers J., Williamson C., Thornton J.G. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012, 344:e3799.
20. Chiang J.Y. Bile acids: regulation of synthesis. J. Lipid Res. 2009, 50:1955-1966.
21. Collier A.C., Tingle M.D., Paxton J.W., Mitchell M.D., Keelan J.A. Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum. Reprod. 2002, 17:2564-2572.
22. Colombo C., Zuliani G., Ronchi M., Breidenstein J., Setchell K.D. Biliary bile acid composition of the human fetus in early gestation. Pediatr. Res. 1987, 21:197-200.
23. Costoya A.L., Leontic E.A., Rosenberg H.G., Delgado M.A. Morphological study of placental terminal villi in intrahepatic cholestasis of pregnancy: histochemistry, light and electron microscopy. Placenta 1980, 1:361-368.
24. Crocenzi F.A., Mottino A.D., Cao J., Veggi L.M., Pozzi E.J., Vore M., Coleman R., Roma M.G. Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G449-G459.
25. Cui J.Y., Aleksunes L.M., Tanaka Y., Fu Z.D., Guo Y., Guo G.L., Lu H., Zhong X.B., Klaassen C.D. Bile Acids via FXR Initiate the Expression of Major Transporters Involved in the Enterohepatic Circulation of Bile Acids in Newborn Mice. Am. J. Physiol Gastrointest. Liver Physiol. 2012.
26. Diaferia A., Nicastri P.L., Tartagni M., Loizzi P., Iacovizzi C., Di L.A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int. J. Gynaecol. Obstet. 1996, 52:133-140.
27. Dixon P.H., Van Mil S.W., Chambers J., Strautnieks S., Thompson R.J., Lammert F., Kubitz R., Keitel V., Glantz A., Mattsson L.A., Marschall H.U., Molokhia M., Moore G.E., Linton K.J., Williamson C. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009, 58:537-544.
28. Dixon P.H., Williamson C. The molecular genetics of intrahepatic cholestasis of pregnancy. Obstet. Med. 2008, 1:65-71.
29. Fulton I.C., Douglas J.G., Hutchon D.J., Beckett G.J. Is normal pregnancy cholestatic?. Clin. Chim. Acta 1983, 130:171-176.
30. +/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats. J. Pharmacol. Exp. Ther. 1993, 267:82-87.
31. Geenes V., Williamson C. Intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 2009, 15:2049-2066.
32. Geenes V.L., Lim Y.H., Bowman N., Tailor H., Dixon P.H., Chambers J., Brown L., Wyatt-Ashmead J., Bhakoo K., Williamson C. A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 2011, 32:1026-1032.
33. Geese W.J., Raftogianis R.B. Biochemical characterization and tissue distribution of human SULT2B1. Biochem. Biophys. Res. Commun. 2001, 288:280-289.
34. Geier A., Dietrich C.G., Gerloff T., Haendly J., Kullak-Ublick G.A., Stieger B., Meier P.J., Matern S., Gartung C. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta 2003, 1609:87-94.
35. Germain A.M., Kato S., Carvajal J.A., Valenzuela G.J., Valdes G.L., Glasinovic J.C. Bile acids increase response and expression of human myometrial oxytocin receptor. Am. J. Obstet. Gynecol. 2003, 189:577-582.
36. Glantz A., Marschall H.U., Lammert F., Mattsson L.A. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42:1399-1405.
37. Glantz A., Marschall H.U., Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40:467-474.
38. Glantz A., Reilly S.J., Benthin L., Lammert F., Mattsson L.A., Marschall H.U. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008, 47:544-551.
39. Hagenbuch B., Dawson P. The sodium bile salt cotransport family SLC10. Pflugers Arch. 2004, 447:566-570.
40. Hagenbuch B., Meier P.J. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch. 2004, 447:653-665.
41. Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Maenpaa J., Edwards R.J., Boobis A.R., Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 1996, 51:403-411.
42. He D., Meloche C.A., Dumas N.A., Frost A.R., Falany C.N. Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate. Biochem. J. 2004, 379:533-540.
43. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 1983, 61:581-587.
44. Heikkinen J., Maentausta O., Ylostalo P., Janne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br. J. Obstet. Gynaecol. 1981, 88:240-245.
45. Israel E.J., Guzman M.L., Campos G.A. Maximal response to oxytocin of the isolated myometrium from pregnant patients with intrahepatic cholestasis. Acta Obstet. Gynecol. Scand. 1986, 65:581-582.
46. Johnston W.G., Baskett T.F. Obstetric cholestasis. A 14year review. Am. J. Obstet. Gynecol. 1979, 133:299-301.
47. Kalaany N.Y., Mangelsdorf D.J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 2006, 68:159-191.
48. Katsuma S., Hirasawa A., Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 2005, 329:386-390.
49. Kauppila A., Korpela H., Makila U.M., Yrjanheikki E. Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. Br. Med. J. (Clin. Res. Ed.) 1987, 294:150-152.
50. Keitel V., Vogt C., Haussinger D., Kubitz R. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 2006, 131:624-629.
51. Kenyon A.P., Tribe R.M., Nelson-Piercy C., Girling J.C., Williamson C., Seed P.T., Vaughan-Jones S., Shennan A.H. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet. Med. 2010, 3:25-29.
52. Kir S., Kliewer S.A., Mangelsdorf D.J. Roles of FGF19 in liver metabolism. Cold Spring Harb. Symp. Quant. Biol. 2011.
53. Kirwan W.O., Smith A.N., Mitchell W.D., Falconer J.D., Eastwood M.A. Bile acids and colonic motility in the rabbit and the human. Gut 1975, 16:894-902.
54. Kitsiou-Tzeli S., Traeger-Synodinos J., Giannatou E., Kaminopetros P., Roma E., Makrythanasis P., Tsezou A. The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 gene as a predisposing factor for intrahepatic cholestasis of pregnancy in Greece. Liver Int. 2010, 30:489-491.
55. Koepsell H., Endou H. The SLC22 drug transporter family. Pflugers Arch. 2004, 447:666-676.
56. Kondrackiene J., Beuers U., Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005, 129:894-901.
57. Kremer A.E., Martens J.J., Kulik W., Rueff F., Kuiper E.M., van Buuren H.R., van Erpecum K.J., Kondrackiene J., Prieto J., Rust C., Geenes V.L., Williamson C., Moolenaar W.H., Beuers U., Oude Elferink R.P. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010, 139(1008-18):1018.
58. Kullak-Ublick G.A., Beuers U., Paumgartner G. Hepatobiliary transport. J. Hepatol. 2000, 32:3-18.
59. Laatikainen T., Hesso A. Determination of serum bile acids by glass capillary gas-liquid chromatography. Clin. Chim. Acta 1975, 64:63-68.
60. Laatikainen T., Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet. Gynecol. 1977, 50:313-318.
61. Laatikainen T., Karjalainen O. Excertion of progesterone metabolites in urine and bile of pregnant women with intrahepatic cholestasis. J. Steroid Biochem. 1973, 4:641-648.
62. Laatikainen T., Lehtonen P., Hesso A. Biliary bile acids in uncomplicated pregnancy and in cholestasis of pregnancy. Clin. Chim. Acta 1978, 85:145-150.
63. Laatikainen T., Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int. J. Gynaecol. Obstet. 1984, 22:91-94.
64. Laatikainen T.J. Fetal bile acid levels in pregnancies complicated by maternal intrahepatic cholestasis. Am. J. Obstet. Gynecol. 1975, 122:852-856.
65. Lang C., Meier Y., Stieger B., Beuers U., Lang T., Kerb R., Kullak-Ublick G.A., Meier P.J., Pauli-Magnus C. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet. Genom. 2007, 17:47-60.
66. Lee R.H., Kwok K.M., Ingles S., Wilson M.L., Mullin P., Incerpi M., Pathak B., Goodwin T.M. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am. J. Perinatol. 2008, 25:341-345.
67. Locatelli A., Roncaglia N., Arreghini A., Bellini P., Vergani P., Ghidini A. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br. J. Obstet. Gynaecol. 1999, 106:498-500.
68. Lunzer M., Barnes P., Byth K., O'Halloran M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986, 91:825-829.
69. Makishima M., Lu T.T., Xie W., Whitfield G.K., Domoto H., Evans R.M., Haussler M.R., Mangelsdorf D.J. Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296:1313-1316.
70. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., Shan B. Identification of a nuclear receptor for bile acids. Science 1999, 284:1362-1365.
71. Marin J.J., Macias R.I., Briz O., Perez M.J., Blazquez A.G., Arrese M., Serrano M.A. Molecular bases of the fetal liver-placenta-maternal liver excretory pathway for cholephilic compounds. Liver Int. 2008, 28:435-454.
72. Marin J.J., Serrano M.A., El-Mir M.Y., Eleno N., Boyd C.A. Bile acid transport by basal membrane vesicles of human term placental trophoblast. Gastroenterology 1990, 99:1431-1438.
73. Marquez B., Van B.F. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr. Drug Targets 2011, 12:600-620.
74. Marschall H.U., Wagner M., Zollner G., Fickert P., Diczfalusy U., Gumhold J., Silbert D., Fuchsbichler A., Benthin L., Grundstrom R., Gustafsson U., Sahlin S., Einarsson C., Trauner M. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005, 129:476-485.
75. Mazzella G., Rizzo N., Azzaroli F., Simoni P., Bovicelli L., Miracolo A., Simonazzi G., Colecchia A., Nigro G., Mwangemi C., Festi D., Roda E. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001, 33:504-508.
76. Meier Y., Zodan T., Lang C., Zimmermann R., Kullak-Ublick G.A., Meier P.J., Stieger B., Pauli-Magnus C. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J. Gastroenterol. 2008, 14:38-45.
77. Meng L.J., Reyes H., Axelson M., Palma J., Hernandez I., Ribalta J., Sjovall J. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 1997, 26:1573-1579.
78. Meng L.J., Reyes H., Palma J., Hernandez I., Ribalta J., Sjovall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J. Hepatol. 1997, 27:1029-1040.
79. Meng L.J., Reyes H., Palma J., Hernandez I., Ribalta J., Sjovall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J. Hepatol. 1997, 27:346-357.
80. Milona A., Owen B.M., Cobbold J.F., Willemsen E.C., Cox I.J., Boudjelal M., Cairns W., Schoonjans K., Taylor-Robinson S.D., Klomp L.W., Parker M.G., White R., Van Mil S.W., Williamson C. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 2010, 52:1341-1349.
81. Milona A., Owen B.M., van M.S., Dormann D., Mataki C., Boudjelal M., Cairns W., Schoonjans K., Milligan S., Parker M., White R., Williamson C. The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G151-G158.
82. Miragoli M., Kadir S.H., Sheppard M.N., Salvarani N., Virta M., Wells S., Lab M.J., Nikolaev V.O., Moshkov A., Hague W.M., Rohr S., Williamson C., Gorelik J. A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart. Hepatology 2011, 54:1282-1292.
83. Mottino A.D., Crocenzi F.A., Pozzi E.J., Veggi L.M., Roma M.G., Vore M. Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity. Am. J. Physiol. Gastrointest. Liver Physiol 2005, 288:G327-G336.
84. Mullenbach R., Bennett A., Tetlow N., Patel N., Hamilton G., Cheng F., Chambers J., Howard R., Taylor-Robinson S.D., Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005, 54:829-834.
85. Mullenbach R., Linton K.J., Wiltshire S., Weerasekera N., Chambers J., Elias E., Higgins C.F., Johnston D.G., McCarthy M.I., Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J. Med. Genet. 2003, 40:e70.
86. Nicastri P.L., Diaferia A., Tartagni M., Loizzi P., Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br. J. Obstet. Gynaecol. 1998, 105:1205-1207.
87. Nies A.T., Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 2007, 453:643-659.
88. Owen B.M., Van Mil S.W., Boudjelal M., McLay I., Cairns W., Elias E., White R., Williamson C., Dixon P.H. Sequencing and functional assessment of hPXR (NR1I2) variants in intrahepatic cholestasis of pregnancy. Xenobiotica 2008, 38:1289-1297.
89. Painter J.N., Savander M., Ropponen A., Nupponen N., Riikonen S., Ylikorkala O., Lehesjoki A.E., Aittomaki K. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur. J. Hum. Genet. 2005, 13:435-439.
90. Palma J., Reyes H., Ribalta J., Hernandez I., Sandoval L., Almuna R., Liepins J., Lira F., Sedano M., Silva O., Toha D., Silva J.J. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J. Hepatol. 1997, 27:1022-1028.
91. Palma J., Reyes H., Ribalta J., Iglesias J., Gonzalez M.C., Hernandez I., Alvarez C., Molina C., Danitz A.M. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992, 15:1043-1047.
92. Papacleovoulou G., Abu-Hayyeh S., Williamson C. Nuclear receptor-driven alterations in bile acid and lipid metabolic pathways during gestation. Biochim. Biophys. Acta 2010.
93. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., Lehmann J.M. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999, 284:1365-1368.
94. Pascual M.J., Serrano M.A., El-Mir M.Y., Macias R.I., Jimenez F., Marin J.J. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. Clin. Sci. (Lond.) 2002, 102:587-593.
95. Pauli-Magnus C., Lang T., Meier Y., Zodan-Marin T., Jung D., Breymann C., Zimmermann R., Kenngott S., Beuers U., Reichel C., Kerb R., Penger A., Meier P.J., Kullak-Ublick G.A. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004, 14:91-102.
96. Paulusma C.C., Folmer D.E., Ho-Mok K.S., de Waart D.R., Hilarius P.M., Verhoeven A.J., Oude Elferink R.P. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology 2008, 47:268-278.
97. Paumgartner G., Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin. Liver Dis. 2004, 8:67-81. (vi).
98. Perez M.J., Macias R.I., Marin J.J. Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect ursodeoxycholic acid. Placenta 2006, 27:34-41.
99. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 2008, 47:376-379.
100. Reyes H., Baez M.E., Gonzalez M.C., Hernandez I., Palma J., Ribalta J., Sandoval L., Zapata R. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J. Hepatol. 2000, 32:542-549.
101. Reyes H., Simon F.R. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin. Liver Dis. 1993, 13:289-301.
102. Reyes H., Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann. Med. 2000, 32:94-106.
103. Rodrigues C.M., Fan G., Wong P.Y., Kren B.T., Steer C.J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 1998, 4:165-178.
104. Ropponen A., Sund R., Riikonen S., Ylikorkala O., Aittomaki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006, 43:723-728.
105. Saini S.P., Sonoda J., Xu L., Toma D., Uppal H., Mu Y., Ren S., Moore D.D., Evans R.M., Xie W. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol. Pharmacol. 2004, 65:292-300.
106. Serrano M.A., Brites D., Larena M.G., Monte M.J., Bravo M.P., Oliveira N., Marin J.J. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J. Hepatol. 1998, 28:829-839.
107. Serrano M.A., Macias R.I., Vallejo M., Briz O., Bravo A., Pascual M.J., St-Pierre M.V., Stieger B., Meier P.J., Marin J.J. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. J. Pharmacol. Exp. Ther. 2003, 305:515-524.
108. Setchell K.D., Dumaswala R., Colombo C., Ronchi M. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J. Biol. Chem. 1988, 263:16637-16644.
109. Shaw D., Frohlich J., Wittmann B.A., Willms M. A prospective study of 18 patients with cholestasis of pregnancy. Am. J. Obstet. Gynecol. 1982, 142:621-625.
110. Sheikh Abdul Kadir S.H., Miragoli M., Abu-Hayyeh S., Moshkov A.V., Xie Q., Keitel V., Nikolaev V.O., Williamson C., Gorelik J. Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS One 2010, 5:e9689.
111. Simon F.R., Fortune J., Iwahashi M., Qadri I., Sutherland E. Multihormonal regulation of hepatic sinusoidal Ntcp gene expression. Am. J. Physiol. Gastrointest. Liver Physiol 2004, 287:G782-G794.
112. Sjovall J., Sjovall K. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels. Ann. Clin. Res. 1970, 2:321-337.
113. Sjovall K., Sjovall J. Serum bile acid levels in pregnancy with pruritus (bile acids and steroids 158). Clin. Chim. Acta 1966, 13:207-211.
114. Sookoian S., Castano G., Burgueno A., Gianotti T.F., Pirola C.J. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J. Hepatol. 2008, 48:125-132.
115. St-Pierre M.V., Stallmach T., Freimoser G.A., Dufour J.F., Serrano M.A., Marin J.J., Sugiyama Y., Meier P.J. Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R1505-R1516.
116. Staudinger J.L., Goodwin B., Jones S.A., Hawkins-Brown D., MacKenzie K.I., LaTour A., Liu Y., Klaassen C.D., Brown K.K., Reinhard J., Willson T.M., Koller B.H., Kliewer S.A. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Nat. Acad. Sci. USA 2001, 98:3369-3374.
117. Stieger B., Meier P.J. Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics 2011, 12:611-631.
118. Strautnieks S.S., Bull L.N., Knisely A.S., Kocoshis S.A., Dahl N., Arnell H., Sokal E., Dahan K., Childs S., Ling V., Tanner M.S., Kagalwalla A.F., Nemeth A., Pawlowska J., Baker A., Mieli-Vergani G., Freimer N.B., Gardiner R.M., Thompson R.J. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998, 20:233-238.
119. Suchy F.J., Balistreri W.F., Heubi J.E., Searcy J.E., Levin R.S. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981, 80:1037-1041.
120. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., Pellicciari R., Auwerx J., Schoonjans K. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009, 10:167-177.
121. Trauner M., Fickert P., Wagner M. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin. Liver Dis. 2007, 27:77-98.
122. Vallejo M., Briz O., Serrano M.A., Monte M.J., Marin J.J. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy. J. Hepatol. 2006, 44:1150-1157.
123. Van Mil S.W., Milona A., Dixon P.H., Mullenbach R., Geenes V.L., Chambers J., Shevchuk V., Moore G.E., Lammert F., Glantz A.G., Mattsson L.A., Whittaker J., Parker M.G., White R., Williamson C. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007, 133:507-516.
124. Van Mil S.W., van der Woerd W.L., van der Brugge G., Sturm E., Jansen P.L., Bull L.N., van den Berg I.E., Berger R., Houwen R.H., Klomp L.W. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004, 127:379-384.
125. Walker I.A., Nelson-Piercy C., Williamson C. Role of bile acid measurement in pregnancy. Ann. Clin. Biochem. 2002, 39:105-113.
126. Wang H., Chen J., Hollister K., Sowers L.C., Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 1999, 3:543-553.
127. Wasmuth H.E., Glantz A., Keppeler H., Simon E., Bartz C., Rath W., Mattsson L.A., Marschall H.U., Lammert F. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut 2007, 56:265-270.
128. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., Messaddeq N., Harney J.W., Ezaki O., Kodama T., Schoonjans K., Bianco A.C., Auwerx J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
129. Williamson C., Gorelik J., Eaton B.M., Lab M., de S.M., Korchev Y. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin. Sci. (Lond.) 2001, 100:363-369.
130. Williamson C., Hems L.M., Goulis D.G., Walker I., Chambers J., Donaldson O., Swiet M., Johnston D.G. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 2004, 111:676-681.
131. Yamamoto Y., Moore R., Hess H.A., Guo G.L., Gonzalez F.J., Korach K.S., Maronpot R.R., Negishi M. Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J. Biol. Chem. 2006, 281:16625-16631.
132. Zhang J., Huang W., Qatanani M., Evans R.M., Moore D.D. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J. Biol. Chem. 2004, 279:49517-49522.